In melanoma, high expression of KDM5B can recruit the H3K9 methyltransferase SETDB1 to interact in the suppression of endogenous retrotransposable elements and block subsequent RNA and DNA sensing pathways as well as type I interferon responses, resulting in the inability of the organism to respond positively to tumor rejection and immune responses (40). Here, KDM5B is linked to neoplasm.